Treatment for Amblyopia Using CureSight Technology
Official title: Treating Amblyopia With CureSight
Run by Alaska Blind Child Discovery · NCT06165705 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new device called CureSight to see if it can help children and teens with amblyopia improve their vision.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years to 20 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Alaska Blind Child Discovery Academic / other |
| Locations | 1 site (Anchorage, Alaska) |
| Trial ID | NCT06165705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 3 to less than 19 years diagnosed with amblyopia due to refractive error, strabismus, or deprivation.
✕Probably not a fit
Patients who cannot participate in visual acuity testing or lack internet access at home may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the efficacy of the CureSight device in treating amblyopia in patients aged 3 to 19 years. Participants will use the CureSight device for 1.5 hours daily, six days a week, over a period of 3 to 6 months. The device employs eye-tracking technology to present tailored visual stimuli to each eye, promoting improved visual acuity. Patients will be recruited from the Alaska Children's EYE & Strabismus clinical practice and will undergo various visual acuity tests throughout the treatment period.
Why it matters
Potential benefit: If successful, this treatment could significantly improve visual acuity in children suffering from amblyopia.
How similar studies have gone: Previous studies using similar dichoptic treatment approaches have shown promising results in improving amblyopia outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * amblyopia Exclusion Criteria: * lack of brain and eye capacity for improved vision lack of home WiFi
Where it's running
-
Alaska Blind Child Discovery
Anchorage, Alaska, United States Recruiting
Study contacts
- Principal investigator: Robert W Arnold, MD — Alaska Blind Child Discovery
- Study coordinator: Robert W Arnold, MD
- Email: eyedoc@alaska.net
- Phone: 9075611917
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Psilocybin-assisted therapy to help adults with amblyopia see more clearly
This study tests whether a single or small doses of psilocybin can boost the effectiveness of amblyopia treatment in adults.
-
Augmented Reality Binocular Therapy for Adult Amblyopia
This trial tests a home-based augmented reality binocular therapy to see if it improves vision in adults 18–40 with anisometropic amblyopia, compared with placebo training.
-
Gabor-based visual training for adults with amblyopia
This study tests a computer-based Gabor training program to see if it can improve vision in adults aged 18–39 with amblyopia due to anisometropia or strabismus.
-
Noninvasive brain stimulation plus augmented reality vision therapy for anisometropic amblyopia in adults
This trial tests whether adding HD-tDCS to AR-based dichoptic therapy can improve vision in adults with anisometropic amblyopia.
-
tDCS for paediatric amblyopia
This study tests whether non-invasive brain stimulation (tDCS) can improve vision for children aged 4–14 with amblyopia who didn’t get enough help from patching.
-
Gamified visual training with occlusion for kids with anisometropic amblyopia
This trial tests two kid-friendly digital games plus patching to see if they improve vision and motivation in children aged 4–7 with anisometropic amblyopia compared with patching alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.